Correction to “Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients”

doi:10.5306/wjco.v16.i8.107778

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (16)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=16

Aug 24, 2025 (publication date) through Aug 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correction

World J Clin Oncol. Aug 24, 2025; 16(8): 107778
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107778

Correction to “Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients”

Niharika Maurya, Rinni Singh, Apul Goel, Atin Singhai, Uday Pratap Singh, Vinita Agrawal, Minal Garg

Niharika Maurya, Rinni Singh, Minal Garg, Department of Biochemistry, University of Lucknow, Lucknow 226007, India

Apul Goel, Department of Urology, King George's Medical University, Lucknow 226003, India

Atin Singhai, Department of Pathology, King George's Medical University, Lucknow 226003, India

Uday Pratap Singh, Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India

Vinita Agrawal, Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, Uttar Pradesh, India

Author contributions: All authors contributed to this paper, and all the authors have agreed with the submission in its present form.

Conflict-of-interest statement: All the authors of the study declare no potential conflict-of-interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Rinni Singh, PhD, Department of Biochemistry, Lucknow University, University Road, Lucknow 226007, India. singhrinni7@gmail.com

Received: May 9, 2025
Revised: May 30, 2025
Accepted: July 2, 2025
Published online: August 24, 2025
Processing time: 144 Days and 21.7 Hours

Core Tip

Core Tip: This manuscript is to add a “correction note” to “Maurya N, Singh R, Goel A, Singhai A, Singh UP, Agrawal V, Garg M. Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients. World J Clin Oncol 2019; 10(4): 166-182 [PMID: 31114749 DOI: 10.5306/wjco.v10.i4.166]”.